Over the years, we have developed a real expertise, predominantly in the cardiovascular field, but we will leverage this expertise to bring value to doctors and…
In Conversation
That is the exciting part of MEA; the fact that you must think outside of the box to solve big issues
If companies bring in the patient perspective from the beginning, the insights they gain could make their clinical trial process go quicker and create a better…
The [Turkish] government perceives plasma products as a strategically important product group and have developed a separate regulation and framework for them
Our goals are threefold: Ensure that Greater Copenhagen is a continued growth engine for all of Denmark, Copenhagen becomes the most sustainable capital in the world,…
Denmark has a unique health data infrastructure with national registers and electronic medical journals for each patient. This data footprint is a true asset for Denmark…
[Denmark] has a prosperous future ahead if the divided healthcare sector can be unified, better conditions for value-based procurements are established, further financial support for the…
This will be one of the largest healthcare transformations in the world in terms of number of centres, size of population served, and complexity
It has become evident during the pandemic that Turkey has a well-established and capable healthcare system with experienced healthcare professionals (HCPs). Considering all these aspects, double-digit…
It is now crystal clear that a one-size-fits-all approach is not the way to go in oncology
Carlo Toniatti, chief scientific officer of IRBM, gives his insights into how the increased participation of early-stage ventures in the drug R&D process and the plethora…
CAR-T, which was touted as a game-changing curative treatment, has been the answer for some patients, but not all
